Related by context. All words. (Click for frequent words.) 69 undergone radical prostatectomy 68 underwent radical prostatectomy 64 clinically localized prostate 61 Uterine cancer 61 epithelial ovarian 61 colon rectal 61 atypical hyperplasia 61 underwent surgical resection 60 gynecologic malignancy 60 faulty BRCA genes 60 fallopian tube carcinoma 60 thromboembolisms 60 ovarian cervical 60 adenomatous polyps 60 underwent brachytherapy 60 undergo radical prostatectomy 60 stage IIIb IV 60 colorectal adenoma 60 Radical prostatectomy 60 contralateral breast 59 HNSCC 59 undergone hysterectomy 59 BRCA1 mutation carriers 59 testicular germ cell 59 nonmetastatic 59 rectal cancers 59 metastatic androgen independent 59 flutamide 59 axillary lymph nodes 59 lobular breast cancer 59 basal cell skin 59 hormone receptor negative 59 PCA3 scores 59 advanced adenomas 59 cancerous prostates removed 58 advanced adenoma 58 undergoing androgen deprivation 58 KRAS mutations occur 58 advanced neoplasia 58 metastatic gastric 58 lobular cancer 58 Prostate Cancer Prostate 58 pharyngeal cancer 58 operable breast cancer 58 parous women 58 prostate colon 58 deCODE ProstateCancer TM 58 undergoing radical prostatectomy 58 advanced epithelial ovarian 58 colorectal neoplasia 58 recurrent metastatic 58 PLX STROKE targeting 58 ductal breast cancer 58 tanned indoors 58 hyperplasia BPH 58 ovarian endometrial 58 undergoing coronary artery 58 nondiabetic patients 58 highest quintile 58 thyrotropin levels 58 hip BMD 58 squamous histology 58 Osteoporosis affects 57 prostate cancer CaP 57 renal cell carcinomas 57 undergone hysterectomies 57 peritoneal cancer 57 Adjuvant chemotherapy 57 endometrial cancers 57 ductal carcinomas 57 metastatic pancreatic 57 nonmelanoma skin cancers 57 prostates removed 57 elevated hsCRP 57 testicular cancers 57 breast uterine 57 faulty BRCA2 gene 57 lung esophageal 57 nonmelanoma 57 prostate TURP 57 bilateral orchiectomy 57 situ LCIS 57 ovarian breast 57 polycystic ovarian syndrome PCOS 57 squamous cell cancers 57 prostate testicular 57 biochemical recurrence 57 progesterone receptor negative 57 histologically confirmed 57 intestinal polyps 57 underwent CABG 57 Adenomas 57 endometriosis ovarian cysts 57 Heavy menstrual bleeding 57 histologic subtype 57 metastatic bladder 57 confidence interval #.#-#.# 57 colorectal adenomas 56 endometrial hyperplasia 56 obese postmenopausal 56 lowest tertile 56 breast endometrial 56 glioma tumors 56 ipsilateral breast 56 colon rectum 56 prostate pancreatic 56 distal colon cancer 56 cystectomy 56 symptomatic BPH 56 uterine cancers 56 ductal cancer 56 distant metastases 56 hormone refractory metastatic prostate 56 invasive lobular 56 LHRH receptor positive 56 colorectal lung 56 polycystic ovary syndrome PCOS 56 pancreatic lung 56 Basal Cell 56 lymph node removal 56 precancerous tumors 56 leiomyomas 56 Prostate Lung Colorectal 56 oral squamous cell 56 psychiatric outpatients 56 lobular carcinoma 56 symptomatic fibroids 56 highest tertile 56 perimenopausal women 56 transitional cell carcinoma 56 osteosarcomas 56 endometrial carcinoma 56 MMSE scores 56 Androgen deprivation therapy 56 Squamous 56 distant metastasis 56 comorbid depression 56 colorectal neoplasms 56 breast ovary 55 recurrent prostate cancer 55 nonproliferative 55 neoplasias 55 pancreatic adenocarcinoma 55 BRCA2 mutations 55 metastatic HER2 positive 55 angioplasties stents 55 prostate carcinoma 55 colorectal polyp 55 metachronous 55 colorectal polyps 55 retrospective cohort 55 uterine cervix 55 relapsed MM 55 colorectum 55 advanced metastatic prostate 55 biochemical relapse 55 develop premenopausal breast 55 HIV seronegative 55 nonvertebral fractures 55 localized prostate cancer 55 CC genotype 55 axillary dissection 55 recurrent NSCLC 55 nodal metastasis 55 diffuse gastric 55 Colon polyps 55 precancerous cervical 55 androgen deficiency 55 tumor histology 55 #.#ng/ml 55 invasive ductal 55 deCODE BreastCancer 55 Benign prostatic hyperplasia BPH 55 diabetes mellitus DM 55 nulliparous women 55 vulvovaginal atrophy 55 breast carcinoma 55 nonmelanoma skin cancer 55 elevated depressive symptoms 55 extracapsular extension 55 urothelial cancer 55 metastatic castrate resistant 55 postmenopausal hormones 55 adjuvant radiotherapy 55 estrogen receptor negative 55 nulliparous 55 autoantibody positive 55 onset diabetes mellitus 55 nonalcoholic steatohepatitis 55 deCODE BreastCancer TM 55 preoperative chemotherapy 55 pT3 55 radical prostatectomy RP 55 Accelerated Partial Breast Irradiation 55 BRCA2 gene mutation 55 % CI #.#-#.# [003] 55 beta carotene supplementation 55 patients undergoing CABG 55 lung resections 54 chronic prostatitis 54 basal cell nevus syndrome 54 ovary uterus 54 drank decaffeinated coffee 54 subtrochanteric 54 enamel defects 54 radical prostatectomy 54 endometrial breast 54 cancerous enlargement 54 cervical lesions 54 undergo lumpectomy 54 locoregional recurrence 54 urothelial carcinoma 54 mammographically 54 recurrent ovarian 54 carotid stenosis 54 gallstone disease 54 hematological disorders 54 Hurthle cell 54 Premenopausal 54 fibroids endometriosis 54 chronic periodontitis 54 squamous cell carcinoma SCC 54 benign prostatic hypertrophy 54 coronary calcification 54 CYT# potent vascular disrupting 54 papillary renal cell carcinoma 54 atrophic gastritis 54 CVD mortality 54 Postmenopausal 54 carotid plaques 54 basal cell cancers 54 BRCA1 mutations 54 ovarian lung 54 undergoing bariatric surgery 54 recurrent venous thromboembolism 54 androgen deprivation therapy 54 proliferative retinopathy 54 pelvic malignancies 54 cervix uteri 54 Urinary incontinence affects 54 recurrent bladder 54 HER2 overexpression 54 LUTS 54 nonfatal stroke 54 HIV HCV coinfected 54 ICDs implanted 54 mutated K ras 54 axillary node 54 bowel polyps 54 dysglycemia 54 cervical carcinoma 54 HER2 amplified 54 adjuvant radiation 54 Papillary 54 carcinoma HNSCC 54 nonischemic 54 endometrial kidney 54 proximal colon 54 prostate adenocarcinoma 54 metastatic castration resistant 54 premenopausal 54 colon rectum breast 54 Menopausal hormone therapy 54 severe periodontitis 54 hormone receptor positive 54 axillary node dissection 54 histological subtype 54 urinary bladder cancer 53 colonic polyps 53 bladder cancers 53 testicular tumors 53 androgen deprivation 53 Framingham Offspring Study 53 metastatic colorectal 53 basal cell carcinoma BCC 53 breast pancreatic 53 prostate cancer HRPC 53 malignant polyps 53 invasive carcinomas 53 NMIBC 53 bladder ovarian 53 hypertension diabetes mellitus 53 aged ≥ 53 locoregional 53 cervical lymph nodes 53 nonsmall cell lung cancer 53 multivariable adjusted 53 adenoma 53 Screening Trial 53 invasive ductal carcinoma 53 cervical intraepithelial neoplasia 53 microbleeds 53 hormone therapy estrogen 53 laryngeal cancer 53 clinically detectable 53 benign prostatic hyperplasia enlarged 53 mL/min/#.# m 2 53 Invasive Breast Cancer 53 salpingo oophorectomy 53 non anthracycline Taxotere 53 infliximab monotherapy 53 pancreatic bladder 53 recurrent VTE 53 metastatic adenocarcinoma 53 HER2 positive cancers 53 invasive lobular carcinoma 53 CIN2 + 53 bacterial prostatitis 53 lymph node involvement 53 BRCA2 carriers 53 bilateral oophorectomy 53 euthyroid 53 gestational diabetes mellitus 53 chemotherapy cisplatin 53 lifetime abstainers 53 arterial thickening 53 postmenopausal osteoporotic women 53 prostate carcinomas 53 undergo prostate biopsy 53 osteopenic 53 adenomatous 53 seminoma 53 Osteoporotic Fractures 53 finasteride Proscar 53 adjuvant hormonal therapy 53 estrogen progestin therapy 53 lung colorectal 53 cutaneous squamous cell carcinoma 53 PCa 53 Uterine fibroids 53 postmenopausal hormone 53 pCR 53 hormonally responsive 53 nonfasting triglyceride levels 53 lobular carcinomas 53 invasive breast cancer 53 precancerous spots 53 pT2 53 colorectal carcinoma 53 prescribed statins 53 anal lesions 53 lymphomas leukemias 53 Rectal cancer 53 external beam radiotherapy 53 Secondhand smoke causes 53 dysplastic nevi 53 benign breast 53 grade squamous intraepithelial 53 TT genotype 53 nondepressed 53 differentiated thyroid 53 stage IIIB IV 53 hypertension hypercholesterolemia 53 Sleep apnea affects 53 familial aggregation 53 PSADT 53 pancreatic prostate 53 resistant hormone refractory 53 neuroendocrine cancers 52 abnormal genital 52 oophorectomy 52 prostate cancer PCa 52 polyp recurrence 52 undergo bariatric surgery 52 cerebral microbleeds 52 prostatic hyperplasia 52 atypical ductal hyperplasia 52 reinterventions 52 osteoporotic fracture 52 bladder tumors 52 Dietary Modification Trial 52 smoldering myeloma 52 precursor lesions 52 HER2 positive metastatic breast 52 Malignant gliomas 52 prostate bladder 52 GISTs 52 cisplatin chemotherapy 52 Endometrial 52 recurrent acute pancreatitis 52 cancerdefine 52 prostate lung 52 cutaneous melanoma 52 Mitomycin C 52 abdominal ultrasounds 52 hydroxyvitamin D concentrations 52 Basal cell 52 pre cancerous polyps 52 Fosamax Boniva 52 CHD CVD 52 densest breasts 52 Women Ischemia Syndrome 52 bronchogenic carcinoma 52 prostatectomy 52 TEAEs 52 HGPIN 52 colorectal bowel 52 tibolone 52 hereditary predisposition 52 BRCA mutations 52 abnormal pap tests 52 pegylated liposomal doxorubicin 52 immunocompetent 52 asymptomatic metastatic 52 Dr. Ahmed Nasrat 52 malignant lesions 52 premalignant lesion 52 Atherosclerosis MESA 52 sleeve lobectomy 52 Premenopausal women 52 esophageal cancers 52 Enlarged prostate 52 underwent bariatric surgery 52 GnRH agonists 52 neoplasia PIN 52 radical nephrectomy 52 colonoscopy sigmoidoscopy 52 dysplastic lesions caused 52 lymph node metastases 52 nondrinkers 52 lipid lowering medications 52 ocular melanoma 52 urgent coronary revascularization 52 Acute myeloid leukemia 52 serum PSA 52 hypogonadal 52 vaginal lesions 52 CI #.#-#.# [002] 52 colorectal prostate 52 nonischemic cardiomyopathy 52 intestinal metaplasia 52 pre menopausal 52 invasive cervical cancer 52 subclinical atherosclerosis 52 specific antigen PSA 52 squamous cell histology 52 telomere lengths 52 ovarian uterine 52 CYP#D# inhibitor 52 subclinical hyperthyroidism 52 renal tumors 52 cervical prostate 52 Squamous Cell 52 thyroid nodules 52 recurrent UTI 52 gastric cardia 52 cervical lymph node 52 hemodialysis patients 52 minimally symptomatic 52 ErbB2 positive 52 metastatic basal cell 52 cerebral infarction 52 atypia 52 gastric adenocarcinoma 52 Nutrition EPIC 52 fibrocystic disease 52 oropharyngeal cancer 52 nonsignificant difference 52 intravenous bisphosphonates 52 pelvic lymphadenectomy 52 CHD mortality 52 SEER database 52 esophageal squamous cell carcinoma 52 sentinel nodes 52 undergone bariatric surgery 52 NHANES III 52 CIN3 52 del 5q MDS 52 situ CIS 52 uterine ovarian 52 colon pancreatic 52 HBeAg negative 51 obstructive coronary artery 51 androgen ablation 51 Waldenstrom macroglobulinemia 51 hypokalemia hypomagnesemia 51 abnormal Pap smears 51 hepatocellular carcinomas 51 gestational hypertension 51 Rheumatoid arthritis affects 51 autoimmune thyroid 51 nonfatal MI 51 phytoestrogen intake 51 adverse reactions incidence 51 invasive carcinoma 51 Squamous cell 51 myocardial infarction MI 51 seminomas 51 medically inoperable 51 colorectal cancer CRC 51 transferrin saturation 51 hematopoietic cancers 51 ductal adenocarcinoma 51 elevated triglyceride levels 51 ovarian pancreatic 51 invasive bladder 51 SEER registry 51 VTEs 51 orchiectomy 51 EBRT 51 conjugated equine estrogen 51 placebo dexamethasone 51 THIS STUDY 51 Multi Ethnic Study 51 Benign Prostatic Hyperplasia BPH 51 gastrointestinal cancers 51 venous thrombosis 51 serous ovarian cancer 51 treat brain aneurysms 51 contralateral breast cancer 51 bladder carcinoma 51 hydroxyvitamin D levels 51 invasive ductal carcinomas 51 BRAF mutated 51 smoke menthol cigarettes 51 castrate resistant prostate cancer 51 atypical moles 51 risk reducing salpingo 51 Nonalcoholic fatty liver 51 ductal lobular 51 perioperative complications 51 malignant neoplasm 51 CARDIA 51 pituitary adenomas 51 lymphatic cancers 51 undergo mastectomy 51 CARDIA study 51 comorbid illnesses 51 awaiting liver transplants 51 Ovary removal 51 BCG refractory 51 treat benign prostatic 51 heterosexually acquired 51 varicocele 51 vaccines gastroenterology 51 postoperative mortality 51 Soft Tissue Sarcoma 51 receiving antiretroviral therapy 51 Epidemiologic studies 51 Hormone pills 51 undergone mastectomies 51 MetS 51 nondiabetic 51 spine fractures 51 Metastatic Prostate Cancer 51 estrogen receptor ER 51 N telopeptide 51 BRCA gene mutations 51 nonobstructive CAD 51 IV NSCLC 51 alpha1 antitrypsin deficiency 51 chlamydial infection 51 Patients Receiving 51 lung pancreatic 51 non valvular atrial 51 endometrial cancer 51 estrogen receptor positive 51 esophagogastric junction 51 tumors GIST 51 impaired glucose metabolism 51 heterozygous familial 51 overt nephropathy 51 precancers 51 P = .# 51 T1DM 51 premenopausal women 51 ejection fractions 51 undergoing CABG 51 Alessandro Riva 51 multivessel disease 51 MGUS 51 urinary symptoms 51 BRCA2 mutation carriers 51 neoplasia 51 Genes Predict 51 vWD 51 anal cancers 51 venous thromboembolisms 51 Digital Mammographic Imaging 51 recurrent myocardial infarction 51 monoclonal gammopathy 51 LNG IUS 51 Atherosclerosis Risk 51 vertebral fracture 51 paclitaxel eluting stents 51 RSV infects 51 oesophageal adenocarcinoma 51 umol L 51 epithelial tumors 51 Vulvar 50 cisplatin resistant 50 oligodendrogliomas 50 abnormal glucose tolerance 50 metabolic syndrome MetS 50 breast cancer recurrences 50 biliary tract cancer 50 rectal cancer 50 malignant brain 50 leucopenia 50 hormonal imbalance menopause 50 radioiodine therapy 50 nonobese 50 SHBG levels 50 BRCA mutation carriers 50 cervical uterine 50 aromatase inhibitor therapy 50 localized prostate 50 mycophenolate mofetil 50 Carotid Revascularization Endarterectomy vs. 50 prior chemotherapy regimens 50 NOLVADEX 50 NSTEMI 50 Endometrial cancer 50 postoperative delirium 50 Median survival 50 sedentary postmenopausal 50 amenorrhoea 50 venous thromboembolic events 50 Renal cell carcinoma 50 astrocytomas 50 AVODART 50 prostate cancer CRPC 50 femoral neck BMD 50 APOE ε4 50 Wisconsin Sleep Cohort 50 hormonally sensitive 50 Non Alcoholic Steatohepatitis 50 Breslow thickness 50 gynecological cancer 50 ischemic cardiomyopathy 50 adenoma recurrence 50 lignan intake 50 primary peritoneal 50 recurrent stroke 50 tertile 50 liver metastasis 50 flavonoid intake 50 poorer prognosis 50 cardiovascular mortality 50 psychiatric comorbidities 50 osteoporotic fractures 50 thiazide diuretic 50 shorter telomere length 50 perioperative mortality 50 androgen suppression therapy 50 femoral neck fracture 50 Androgen Deprivation Therapy 50 postoperative pulmonary 50 onset idiopathic hypogonadism 50 folic acid takers 50 breast carcinomas 50 androgenic alopecia 50 prognostic variables 50 lacunar 50 prophylactic mastectomies 50 testicular prostate 50 non aspirin NSAIDs 50 IPAH 50 microscopic colitis 50 BRCA deficient 50 metastatic malignant 50 non resectable metastatic 50 rectal gonorrhea 50 carotid atherosclerosis 50 cognitively normal 50 EUS FNA 50 baseline A1C 50 nonfatal cardiac arrest 50 subependymal giant cell 50 liver transplant recipients 50 preintervention 50 colorectal gastric 50 Colorectal Cancers 50 postmenopausal women 50 Testosterone Therapy 50 idiopathic PAH 50 Gynecological Cancers 50 5-FU/LV 50 Adenocarcinoma 50 asymptomatic PAD 50 metastatic prostate 50 sociodemographic characteristics 50 bladder prostate 50 Complication rates 50 noncardiac 50 hypermethylated 50 T1a 50 ABCB1 50 mixed hyperlipidemia 50 asymptomatic carotid stenosis 50 Crohn colitis 50 mammographic density 50 protein excretion 50 Meningiomas 50 hypercoagulable 50 non squamous 50 rosuvastatin #mg 50 Small Intestine 50 adjunctive placebo 50 ovarian carcinoma 50 oral antidiabetic medication 50 hypoparathyroidism 50 leukemia AML 50 mutated BRCA1 50 Memory Study WHIMS 50 waist circumferences 50 neurocognitive function 50 nonpregnant women 50 Low Testosterone 50 endarterectomy 50 Anaplastic 50 solar keratosis 50 undergoing hysterectomy 50 carcinoma HCC 50 Screening Trial DMIST 50 acute myeloid 50 receiving concomitant corticosteroids 50 recurrent coronary 50 intermittent exotropia 50 uterus womb 50 BRCA mutation 50 bile duct cancers 50 Androgenetic Alopecia 50 non squamous NSCLC 50 aerodigestive tract 50 systolic hypertension 50 acute myocardial infarctions 50 loop diuretics 50 colorectal pancreatic 50 Asymptomatic 50 Avandia Actos 50 CYPHER Stent 50 Glioblastoma Multiforme GBM 50 nondemented 50 irregular menstrual cycles 50 alendronate Fosamax 50 prospective longitudinal 50 dietary questionnaires 50 nonvertebral fracture 50 bowel cancers 50 Netherlands Cohort Study 50 arterial thromboembolic events 50 Shark cartilage 50 superficial bladder cancer 50 normal karyotype 49 acrylamide intake 49 heterosexually acquired HIV 49 triglyceride concentrations 49 BMD measurements 49 lobular involution 49 uterine tumors 49 Glioblastoma multiforme GBM 49 breast cancer recurrence 49 micrometastases 49 colon rectal cancer 49 neoadjuvant therapy 49 Health Initiative Observational 49 hereditary hemochromatosis 49 traumatic amputations 49 secondary hypogonadism 49 carcinomas 49 glioma rarer 49 orchitis 49 renal carcinoma 49 postoperative atrial fibrillation 49 Hormone Refractory Prostate Cancer 49 trials RCTs 49 colon esophageal 49 testosterone supplementation 49 fragility fracture 49 cryptogenic 49 clinicopathologic 49 frequently benign tumor 49 Thyroid nodules 49 urinary tract symptoms LUTS 49 thyroid dysfunction 49 preventive mastectomies 49 breast colorectal 49 HIV uninfected 49 anovulatory infertility 49 relapsed ALL 49 Hodgkin lymphoma HL 49 bladder colon 49 Colorectal cancer incidence 49 emphysema chronic bronchitis 49 BRCA1 BRCA2 49 observational cohort study 49 bone metastases 49 GBA mutations 49 chemoradiotherapy 49 Celiac disease affects 49 undetectable HBV DNA 49 Basal cell carcinoma 49 VaD 49 antidiabetic medication 49 % CI #.#-#.# [008] 49 urine cytology 49 HNPCC 49 squamous cell carcinomas 49 dietary calcium intake 49 systolic dysfunction 49 androgen excess 49 Naive Patients 49 hamartomas 49 pharyngeal cancers 49 pediatric malignancies 49 adjuvant therapy 49 comorbidities 49 carcinoid tumor 49 colorectal cancer 49 K ras mutations 49 extracolonic findings 49 chronic myeloid 49 squamous cell skin 49 BPH afflicts approximately 49 B Cell Lymphoma 49 KRAS mutations 49 DAS# scores 49 cirrhotic 49 intravesical therapy 49 hepatocellular liver 49 benign uterine 49 colorectal breast 49 radiation therapy SBRT 49 abnormal mammogram 49 Soy isoflavones 49 metastatic ovarian cancer 49 ASCUS 49 NECK CANCER SUPPORT GROUP 49 psychiatric morbidity 49 thyrotoxicosis 49 seminal vesicle invasion 49 glucocorticoid induced osteoporosis 49 Homocysteine levels 49 liabilities Noncurrent 49 breast caner 49 lung cancer NSCLC 49 chronic HBV infection 49 eccrine 49 colon polyps 49 refractory ovarian cancer 49 poor metabolizers 49 prostate ovarian 49 serum prostate 49 Osteoarthritis affects 49 Replication NCS R 49 castrate resistant 49 Hormonal therapy 49 mIU L 49 Communities ARIC study 49 papillary carcinoma 49 kg m² 49 CHEK2 49 fatty breasts 49 DCIS ductal carcinoma 49 renal dysfunction 49 coronary revascularization 49 adjuvant chemotherapy 49 AAT deficiency 49 node metastases 49 Wactawski Wende 49 Her2 positive 49 Carcinoid tumors 49 infiltrating ductal carcinoma 49 pre malignant lesions 49 SUVmax 49 Epithelial ovarian cancer 49 pre cancerous growths 49 enlarged prostate glands 49 intravenous RSD# 49 epithelial ovarian cancer 49 neoadjuvant chemotherapy 49 CP CPPS 49 benign noncancerous 49 peritoneal carcinomatosis 49 Operative mortality 49 lupus erythematosus 49 Boss Hogg T shirt 49 serodiscordant couples 49 antigen PSA 49 limiting generalizability 49 colorectal ovarian 49 Young Adults CARDIA 49 breast cervical 49 vulvar cancers 49 epithelioid 49 untreated celiac disease 49 Acute Myeloid Leukaemia AML 49 definite stent thrombosis 49 MYH9 gene 49 prostate abnormalities 49 LV dysfunction 49 NSTE ACS 49 Chlamydia infection 49 metastatic lung cancer 49 Insulin sensitivity 49 sentinel node biopsy 49 Malignant Melanoma 49 DVT PE 49 Chronic myeloid leukemia CML 49 malignant pleural mesothelioma 49 keratoses 49 overexpress HER2 49 prostate biopsies 49 histological diagnosis 49 squamous cell lung cancer 49 dyslipidaemia 49 Severe Primary IGFD 49 Baltimore Longitudinal Study 49 sentinel lymph node biopsy 49 cell carcinomas 49 Sjögren syndrome 49 Univariate analysis 49 retrospective cohort study 49 brivanib 49 microalbumin 49 narcolepsy cataplexy 49 myocardial infarctions MIs 49 immunology neurology gastroenterology dermatology 49 Recurrences 49 metastatic renal cell carcinoma 49 Calcium vitamin D 49 familial clustering 49 collagenous colitis 49 gastric cancers 49 latent celiac disease 49 colorectal liver metastases 49 HRQOL 49 CaP 49 mucinous 49 squamous 49 NATRECOR R 49 goserelin 48 unfavorable genotypes 48 nasopharyngeal carcinoma 48 awaiting kidney transplants 48 Cystic 48 prostate cancers 48 BRAF V#E mutation 48 oxycodone IR 48 atopic asthma 48 polyps growths 48 Swedish Mammography Cohort 48 genetic variants associated 48 Postpartum depression affects 48 morbidly obese adolescents 48 pathologic fractures 48 primary hypercholesterolemia 48 postmenopausal 48 Postmenopausal Women 48 containing drospirenone 48 leukoplakia 48 dysplastic lesions 48 preoperative PSA 48 digital rectal exams 48 sorafenib Nexavar 48 artery calcification 48 breast conserving 48 urologic cancers 48 Squamous Cell Carcinoma 48 nonhormonal 48 coronary artery calcification 48 abnormal cytology 48 menopausal hormone therapy 48 nodal metastases 48 rosuvastatin Crestor 48 curable cancers 48 psychiatric comorbidity 48 letrozole Femara 48 oxycodone CR 48 eribulin 48 chemoradiation 48 C1 INH deficiency 48 serum GGT 48 grade serous ovarian 48 BCG vaccinated 48 penis scrotum 48 squamous cell 48 pheochromocytomas 48 % CI #.#-#.# [006] 48 metaplasia 48 COPD exacerbation 48 elevated fasting glucose 48 NLSY 48 nonseminoma 48 testosterone deficiency 48 ruptured aneurysms 48 LDL cholesterol concentrations 48 APOL1 48 Hepatocellular Carcinoma HCC 48 #mg/dL [001] 48 Bladder cancer 48 risedronate Actonel 48 Study ARIC 48 Peritoneal 48 fragility fractures 48 benign lesions 48 spontaneous preterm delivery 48 apolipoprotein E4